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A woman with severe, refractory bulimia nervosa (BN) underwent treatment for comorbid
depression using repetitive transcranial magnetic stimulation (rTMS) of the dorsomedial
prefrontal cortex (DMPFC) using a novel technique. Unexpectedly, she showed a rapid,
dramatic remission from BN. For 5months pre-treatment, she had reported two 5-h binge-
purge episodes per day. After rTMS session 2 the episodes stopped entirely for 1week;
after session 10 therewere no further recurrences. Depression scores improvedmore grad-
ually to remission at session 10. Full remission from depression and binge-eating/purging
episodes was sustained more than 2months after treatment completion. In neuroimaging
studies, the DMPFC is important in impulse control, and is underactive in BN. DMPFC–
rTMS may have enhanced the patient’s ability to deploy previously acquired strategies to
avoid binge-eating and purging via a reduction in her impulsivity. A larger sham-controlled
trial of DMPFC–rTMS for binge-eating and purging behavior may be warranted.
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BACKGROUND
Eating disorders, including anorexia nervosa (AN), bulimia ner-
vosa (BN), and binge-eating disorder (BED), have a lifetime preva-
lence of ∼5% in women (Hudson et al., 2007), and are associated
with signiﬁcant morbidity and mortality (Fichter et al., 2008).
Eating disorders are commonly associated with affective disor-
ders (Mangweth et al., 2003) such as major depressive disorder
(MDD). Treatment options for these disorders include cognitive
behavioral therapy, pharmacotherapy, or both (Brownley et al.,
2007; Mitchell et al., 2007; Shapiro et al., 2007; Vocks et al., 2010).
While both treatment options aremoderately effective in the short
term, relapse rates are high and refractory cases are common.
Repetitive transcranial magnetic stimulation (rTMS) is an
emerging option in the treatment of refractory depression
(Daskalakis et al., 2008; Lam et al., 2008; Schonfeldt-Lecuona et al.,
2010). To date, few studies have examined the use of rTMS in
patients with eating disorders, and results have been mixed using
the conventional rTMS target in the dorsolateral prefrontal cortex
(DLPFC; Hausmann et al., 2004; Walpoth et al., 2008; Van den
Eynde et al., 2010). However, neuroimaging studies in eating dis-
orders suggest structural and functional abnormalities of other
regions, such as the anterior cingulate cortex and the neighbor-
ing dorsomedial prefrontal cortex (DMPFC; Muhlau et al., 2007;
Schafer et al., 2010; Joos et al., 2011), suggesting that these could
be more effective rTMS targets. Of note, there is also a converg-
ing body of evidence from lesion, stimulation, morphometric,
and functional connectivity studies highlighting the DMPFC as
a critical nexus of structural and functional pathology in MDD,
suggesting that the DMPFC may be an effective rTMS target for
MDD as well (Stefurak et al., 2003; Koenigs et al., 2008; Koenigs
and Grafman, 2009; Sheline et al., 2010; Bora et al., 2012).
Here, we report a case of a woman suffering from severe,
refractory BN, and comorbid MDD. She was originally referred
for MRI-guided rTMS of the DMPFC for MDD as part of an
ongoing case series. However, during treatment, she serendipi-
tously achieved rapid, complete, and sustained remission from
both bulimia and MDD symptoms that persisted for more than
2months. This case report will focus primarily on the unexpected
improvement in her BN symptoms, as the effects of DMPFC–
rTMS in MDD across the entire case series will be the subject of a
larger future publication.
CASE PRESENTATION
BACKGROUND
A 43-year-old woman, divorced with no children, on leave from
her work as a pharmacist, had a longstanding history of severe and
refractory AN, binge-eating/purging type. She was ﬁrst hospital-
ized at 15 years of age with restricted eating and extreme weight
loss (height, 157 cm, weight, 31.7 kg; BMI, 12.9) and diagnosed
with AN. She began to engage in binge-eating episodes shortly
thereafter, and added self-induced vomiting and some compen-
satory exercise at age 20. Her ﬁrst episode of depression developed
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at the same age. The frequency and severity of depressive episodes,
binge-eating and self-induced vomiting increased steadily over the
next 20 years.
There was a marked increase in illness severity in 2007, when
her husband of 8 years ended their relationship. For approximately
4 years thereafter, she engaged in one to two binge-eating episodes
per day, each lasting at least 5 h, followed immediately by purg-
ing by vomiting. By 2010, she was engaging in binge-eating and
purging almost to the exclusion of all other activities including
socializing, paying bills, or doing errands. She reported that she
would often remain awake throughout the night to continue these
behaviors, and at times would have insufﬁcient time to shower
or dress in the morning due to the duration and intensity of the
episodes. Her weight gradually increased into the normal range as
a consequence of the severity of her bulimic behavior, so that her
diagnosis shifted to BN. As of June of 2010, she was obliged to give
up her work as a pharmacist due to the severity of her illness.
There was no history of hypomania or mania, panic disorder,
obsessions or compulsions, delusions or hallucinations, or self-
harmbehavior, either past or present. She hadnever engaged in any
substance use aside from one to two alcoholic drinks per month.
Her past medical history was remarkable for osteopenia and poor
dentition secondary to purging. Although there were no family
members with any formal psychiatric diagnosis, her mother and
sister were reported to have symptoms of MDD, and a maternal
aunt was reported to have symptoms of AN. She did have a history
of paternal physical abuse in childhood.
From age 30, she had had unsuccessful trials of multiple SSRIs,
trazodone, and desipramine, with add-on treatment using risperi-
done, quetiapine, methylphenidate, and modaﬁnil. She had also
unsuccessfully pursued several courses of intensive treatment for
eating disorders, including four admissions to inpatient programs,
six admissions to day hospital programs, and participation in
mindfulness-based stress reduction, cognitive behavioral therapy,
occupational therapy through a community outreach program,
group therapy, and intensive treatment for her trauma history.
In June 2010, she had attempted a day program at the Toronto
General Hospital but was unable to signiﬁcantly modify her eat-
ing behavior and was obliged to withdraw. In October 2010, at a
weight of 47 kg (BMI, 18.9), she entered a 6-week inpatient treat-
ment andwas able to normalize her eating in this setting. However,
she suffered a complete relapse 4 days after discharge to outpatient
treatment, returning to twice-daily 5 h binge-eating episodes fol-
lowed by purging, to the exclusion of most other activities. These
episodes continued uninterrupted for the next 5months until the
beginning of her rTMS treatment.
INITIAL PRESENTATION
In April, 2011, she was referred for rTMS to address her refractory
depression, rather than her disordered eating. At her intake assess-
ment, she reported a current episode of depression beginning in
2009,with daily symptoms of lowmood,partial anhedonia, loneli-
ness, highly impaired concentration and decision-making abilities,
socialwithdrawal,decreased energy andmotivation,andpersistent
thoughts of hopelessness and self-criticism about her inability to
follow throughwith plans. She had thoughts that life was no longer
worth living, but no speciﬁc suicidal intent or plan. She reported
her depressive symptoms as moderately improved on a regimen
of venlafaxine XR 300mg once daily and desvenlafaxine 50mg
once daily, which she had been taking for the last 3months. Her
baseline pre-treatment scores were 26 on the 17-item Hamilton
Depression Rating Scale (HamD17) and 28 on the Beck Depres-
sion Inventory-II (BDI-II) self-report, suggesting a moderate to
severe level of depressive symptoms.
In addition, she reported symptoms of disordered eating with
twice-daily 5 h binges followed by purging for the last 5months.
She had a distortion of body image, describing her own appear-
ance as “too old” and “funny-looking.” Her menses had been
present over the past year. At this time her weight was 50 kg (BMI,
20.3). She reported her current major stressors as being primarily
around loneliness, separation from her husband, difﬁculty follow-
ing through on her plans, and difﬁculty managing her eating and
purging behavior.
TREATMENT METHODS
Following assessment, she was accepted for treatment and under-
went a preliminaryMRI, followedby 20 sessions of neuronavigated
rTMS, one session per weekday, over 4weeks. Neuronavigation
employed the Visor 2.0 frameless stereotaxic system (Advanced
Neuro Technologies,Madison,WI,USA) to position the coil at the
scalp point at minimum distance from the coordinate (x 0, y + 28,
z + 45) in standard space (Talairach and Tournoux, 1988), corre-
sponding to DMPFC. Stimulation employed a MagPro R30 rTMS
device connected to the ﬂuid-cooled Cool-DB80 coil (MagVen-
ture, Farum, Denmark), which has windings angled at 120˚ rather
than 180˚ to achieve greater depths of stimulation.
Each treatment session involved stimulation of right then left
DMPFC with 60 trains of 10Hz stimulation at 120% of resting
motor threshold in 5 s trains with a 10-s inter-train interval, for
a total of 3000 pulses to each hemisphere, as per a previously
published protocol (Hadley et al., 2011). Prior to the ﬁrst session,
motor thresholds for ﬂexion of the contralateral hallux were deter-
mined for each hemisphere using previously published methods
(Schutter and vanHonk, 2006; Hayward et al., 2007). The primary
motor cortical region for the lower extremity lies on the medial
wall at depths comparable to the DMPFC. Preferential stimula-
tion of each hemisphere was achieved by orienting the coil at 90˚
tomidline, so that the direction of current ﬂow at the coil intersec-
tion was aimed toward the hemisphere to be stimulated. As in the
previous reports, this technique produced asymmetric motor acti-
vation of the contralateral lower extremity duringmotor threshold
determination. The same approachwas used for stimulation of left
and right DMPFC during treatment.
COURSE AND OUTCOME
The patient tolerated the treatment well. The only adverse effects
were headache and localized scalp discomfort around the site of
stimulation during the ﬁrst 10 sessions, and mild pre-syncopal
episodes on the ﬁrst and second sessions. On both occasions, she
was able to recover with a brief period of rest and complete the
session.
Her depression symptoms remitted over the course of treat-
ment on both self- and clinician-rated measures, accompanied by
marked and rapid improvement in daily psychosocial functioning.
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Her baseline BDI-II score, monitored daily, dropped from 28 at
baseline to 7 after 11 sessions, and remained in this range there-
after. On the HamD17,monitored weekly, her score dropped from
26 at baseline to 0 by the end of treatment.
The more striking and unexpected outcome was that, after the
second session of treatment, both the binge-eating and the purg-
ingbehaviors stopped abruptly (Figure 1).As previously noted, the
patient had been referred for rTMS for depression and there was
no prior expectation of improvements in her disordered eating.
For this reason, standardized measures of eating disorder severity
using standard scales are not available. However, even using the
coarse measure of daily binge incidence, the degree of improve-
ment was pronounced. Using a daily log, she reported complete
remission throughout the remainder of the ﬁrst week of treatment.
During sessions 6–10, she reported a single binge-purge episode
per day. These resolved once again by the session 11 of treatment,
and did not recur thereafter. Subjectively, she reported that she
found herself better able to apply strategies she had learned in
therapy to redirect her thoughts and behavior away from binge-
eating and purging. Speciﬁcally, she reported a reduction in her
sense of urgency or impulsiveness when she had the urge to binge
or purge, and an enhanced ability to make other choices and fol-
low through on planned alternative behavior. As she continued
to be successful in resisting these impulses, a sense of optimism
and positive self-esteem developed, and her mood then began to
improve.
Full remission of both depression and disordered eating was
maintained for a period of 64 days after the last session of treat-
ment. On days 65, 70, and 71 post-treatment, she had a single
episode of binge-eating and purging. She had reported the emer-
gence of a signiﬁcant psychosocial stressor (contact with her for-
mer spouse) immediately prior to this recurrence, and requested a
repeat course of rTMS to avoid relapse. A second 20-session course
of rTMS was initiated on day 82 post-treatment, by which time
her BDI-II had increased to 20 and her HamD17 had increased to
FIGURE 1 | Binge-purge episode incidence before, during, and after
rTMS of the DMPFC. Full remission from binge-purge episodes was
achieved by the third week of treatment, and was sustained for 9weeks
after the completion of treatment. Note that the treatment and
post-treatment periods are separated purely for schematic reasons in this
ﬁgure; in terms of temporal sequence, post-treatment week 1 immediately
followed rTMS treatment week 4 with no intervening period.
11. After 5 sessions of treatment these had decreased to 7 and 7,
respectively. Binge-eating and purging once again resolved com-
pletely after the ﬁrst session of rTMS. She remained in remission
from both depression and disordered eating throughout the rest
of the course of treatment.
DISCUSSION
The presence of severe, disabling, and refractory symptoms is
unfortunately very common in patients with AN and BN. In this
case, prior to rTMS, the patient had suffered a 20-year history of
poor response to treatment, despite the use of all available treat-
ment modalities. Given this context, the achievement of rapid and
complete remission with 20 sessions of rTMS over the DMPFC
was remarkable, unanticipated, and serendipitous. The small pre-
vious literature on rTMS in disordered eating has shown mixed
results with stimulation of the DLPFC. This case suggests that
rTMS of the DMPFC could potentially be a more successful
approach.
Although previous studies have applied short bursts of TMS to
the DMPFC in non-ED patients and in healthy controls, to our
knowledge this is the ﬁrst report of a prolonged course of high-
intensity DMPFC–rTMS in eating disorders. Aside from transient
local pain during the initial sessions of treatment, and mild pre-
syncopal episodes on sessions 1 and 2, there were no adverse effects
identiﬁed. Although detailed neuropsychological testing was not
performed in this patient, we will note here that other patients
in our clinic have undergone the same treatment protocol with
either neutral or mildly beneﬁcial effects on memory, attention,
and executive function (data in preparation) – a result in keeping
with previous rTMS literature on DLPFC stimulation (Guse et al.,
2010).
We note that since rTMS was delivered in an open-label fash-
ion, we cannot conclusively rule out improvement due to the
non-speciﬁc effects of placebo or daily therapeutic contact. How-
ever, several factors argue against non-speciﬁc mechanisms in this
case. First, the patient was undergoing treatment for depression
rather than disordered eating, and neither she nor the treat-
ment team had anticipated any effects of rTMS on her eating
behavior. Second, during both courses of rTMS, the improve-
ment in binge-eating and purging distinctly preceded the course
of improvement in her symptoms of depression, rather than the
other way around. The patient’s subjective report was consistent
with this: ﬁrst, the binges abruptly resolved, then, with continuing
remission, her sense of conﬁdence and optimism began to grow
and her mood improved. Third, the patient had already under-
gone several courses of inpatient treatment involving much more
intensive, speciﬁcally directed therapies against disordered eating,
with much longer periods of patient contact, yet had shown lit-
tle sustained improvement. Fourth, in previous studies, neither
active nor sham rTMS of a different target, the DLPFC, achieved
improvements comparable to those in this case (Walpoth et al.,
2008). Thus we consider it unlikely that any effects of expectancy,
patient contact, or non-speciﬁc sensory effects of rTMS (noise,
pain, etc.) are sufﬁcient to account for the rapid, complete, and
sustained remission observed in this case. Nonetheless, future
studies might expand upon the present observation more rigor-
ously by including a sham rTMS control group and by obtaining
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electrolytes and other laboratory investigations to complement the
subjective reports of patients’ eating diaries.
What mechanismsmight account for the unanticipated success
of DMPFC stimulation in this case of refractory BN? In recent
years, a series of neuroimaging studies have speciﬁcally linked this
brain region to impulse control and behavioral inhibition. Stud-
ies in healthy subjects have shown the DMPFC to be important
in self-inhibition of actions, behaviors, and emotional reactions
(Brass and Haggard, 2007; Kuhn et al., 2011). This region also
activates during successful self-inhibition of loss-chasing in patho-
logical gamblers (Campbell-Meiklejohn et al., 2008), and during
food cravings (Kober et al., 2010) and cigarette cravings in smokers
(Brody et al., 2007). It has also recently been shown to be hypoac-
tive during the viewing of food cues in patientswith BN (Joos et al.,
2011). If the DMPFC is important for the successful inhibition of
impulses to binge and purge, then rTMS-induced enhancement
of its activity may explain the rapid remission of symptoms. In
keeping with this proposal, a recent case report noted successful
suppression of alcohol cravings in a patient with severe, refractory
alcohol dependence, with rTMS of the same region (De Ridder
et al., 2011).
The DMPFC is also a key region for cognitive reappraisal
and the self-regulation of emotion (Wager et al., 2008). Enhanc-
ing DMPFC activity could therefore help to reduce the affective
response to aversive stimuli, such as traumatic memories, or other
conditioned affective responses. In this patient, the synergistic
effects of improvedmood, decreased anxiety, and impulsivity may
have combined to normalize her eating behavior.
Another potentially important factor may have been the
patient’s extensive prior training in cognitive and behavioral
techniques for avoiding binge-eating and purging behaviors,
acquired during previous admissions. Subjectively, she reported
that she had always had difﬁculty consistently implementing these
techniques in practice, and that an early effect of the rTMSwas that
she found herself more able to apply the techniques successfully.
This may have reﬂected a decrease in her impulsivity, or in her
affective response to an urge to binge or purge. Hence, the rapid
response in this case could potentially reﬂect an enabling effect
of the rTMS upon previously acquired cognitive and behavioral
skills, via decreases in impulsivity and affective instability.
On a technical note, the implicated region in the neuroimaging
studies of BN lies near the border of the anteriormid-cingulate and
adjacent paracingulate cortex, at least 4 cm deep to scalp. Conven-
tional ﬂat ﬁgure-8 coils may not be capable of inducing activation
at these depths. However, the 120˚-angled coil used in this case
can generate ﬁelds of up to 0.5 T at 4 cm depth. Hence, the use
of a deep-stimulating coil may be essential to the success of the
treatment.
CONCLUDING REMARKS
In conclusion, this case suggests that rTMS of theDMPFC is worth
further investigation as a treatment for refractory binge-eating
and purging behaviors. A randomized, sham-controlled trial, in a
larger group of patients, would be helpful in establishing whether
the successful outcome of this case can be replicated, and to what
degree non-speciﬁc mechanisms such as expectancy and thera-
peutic contact contribute to the overall success of the treatment.
If successful, such a trial could lead to a safe, well-tolerated, and
effective treatment option for patients with severe and otherwise
refractory eating disorders.
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